Skip to main content
. 2021 Nov 12:jiab566. doi: 10.1093/infdis/jiab566

Table 1.

Serological Status and Seroprevalence Among Danish Blood Donors by Region in Denmark

Serological Status and Seroprevalence Weeks 41 to 44, 2020 Weeks 5 to 8, 2021
SARS-CoV-2 serological status
 Seronegative, n (%)
  Capital 6419 (29) 5395 (29)
  Central Denmark 5255 (24) 4919 (26)
  North Denmark 2361 (11) 1991 (11)
  South Denmark 4905 (22) 3825 (20)
  Zealand 3191 (14) 2759 (15)
  Total 22131 (100) 18889 (100)
 Seropositive, n (%)
  Capital 288 (52) 706 (47)
  Central Denmark 99 (18) 317 (21)
  North Denmark 29 (5) 118 (8)
  South Denmark 89 (16) 161 (11)
  Zealand 54 (10) 207 (14)
  Total 559 (100) 1509 (100)
Donor seroprevalence
 Unadjusted seroprevalence, %
  Capital 4.29 11.6
  Central Denmark 1.85 6.05
  North Denmark 1.21 5.60
  South Denmark 1.78 4.04
  Zealand 1.66 6.98
  Total 2.46 7.40
 Adjusted seroprevalence, % (95% CI)a
  Capital 3.98 (2.99–4.61) 11.6 (10.4–12.6)
  Central Denmark 1.44 (.48–1.95) 5.81 (4.75–6.60)
  North Denmark 0.78 (.00–1.38) 5.34 (4.06–6.47)
  South Denmark 1.37 (.41–1.88) 3.72 (2.66–4.46)
  Zealand 1.25 (.27–1.83) 6.77 (5.54–7.85)
  Total 2.08 (1.17–2.47) 7.21 (6.30–7.78)

Serological status and seroprevalence among Danish blood donors stratified by region for weeks 41 to 44, 2020 and weeks 5 to 8, 2021. The exact numbers stratified by region and age were used in the estimation of the number of SARS-CoV-2 seropositives. However, due to the low number of seropositives in specific age strata for some regions, only total numbers and seroprevalences per region are presented.

Abbreviations: CI, confidence interval; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

Seroprevalence adjusted for assay sensitivity and specificity.